14 articles for AL Smith
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
An evaluation of central penetration from a peripherally administered oxytocin receptor selective antagonist in nonhuman primates.
Emory University
Discovery of 1H-pyrazol-3(2H)-ones as potent and selective inhibitors of protein kinase R-like endoplasmic reticulum kinase (PERK).
Amgen
Investigation of an F-18 oxytocin receptor selective ligand via PET imaging.
Emory University
Carbon-11 N-methyl alkylation of L-368,899 and in vivo PET imaging investigations for neural oxytocin receptors.
Yerkes National Primate Research Center
Selective class I phosphoinositide 3-kinase inhibitors: optimization of a series of pyridyltriazines leading to the identification of a clinical candidate, AMG 511.
Amgen
Structure-based design of a novel series of potent, selective inhibitors of the class I phosphatidylinositol 3-kinases.
Amgen
Synthesis and evaluation of C-11, F-18 and I-125 small molecule radioligands for detecting oxytocin receptors.
Emory University
A novel series of potent gamma-secretase inhibitors based on a benzobicyclo[4.2.1]nonane core.
Merck Sharp & Dohme Research Laboratories
2-Aryl tryptamines: selective high-affinity antagonists for the h5-HT2A receptor.
Merck Sharp & Dohme Research Laboratories
Solid-phase synthesis of 2,3-disubstituted indoles: discovery of a novel, high-affinity, selective h5-HT2A antagonist.
Merck Sharp & Dohme Research Laboratories
Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors
Aeterna Zentaris